
Achieve Life Sciences, Inc.: updates and filings
Price
$5.56
November 20, 2026Market cap $612M
What Ploutos Investor adds for Achieve Life Sciences
Part of Ploutos Investor, €9.99 a month
- The full history: 8 fiscal years, from 2018
- The estimated fair value, with its range and its certainty
- The full analysis, 18 a month
- More questions to the chat on its filings
- Excel with every year
- An email when it reports, changes its dividend or an officer buys
Sign in with a free account to see the last 5 fiscal years.
What comes next, and what happened
Its next results and latest dividend, and the filings that told of something: results, deals, people, debt. In plain words, each linked to the filing.
November 2026
October 2026
August 2026
May 2026
Its SEC filings
What it has filed lately, newest first, linked to the document itself.
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 16, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Nov 10, 2026Quarterly reportfor the period to Sep 30, 2026Form10-Q
- Nov 10, 2026Results of operationsForm8-K
- Oct 1, 2026Officer or director changeForm8-K
- Aug 17, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 14, 2026Other material eventsForm8-K
- Aug 13, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Aug 11, 2026Quarterly reportfor the period to Jun 30, 2026Form10-Q
- Aug 11, 2026Results of operationsForm8-K
- Jul 28, 2026Over-5% holder statement (passive) (amendment)FormSCHEDULE 13G/A
- Jul 27, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 8, 2026Over-5% holder statement (passive)FormSCHEDULE 13G
- Jul 6, 2026Amended articles or bylaws, shareholder voteForm8-K
- Jun 8, 2026Annual report to shareholdersfor the period to Dec 31, 2025FormARS
- Jun 8, 2026Annual meeting proxy statementFormDEF 14A
- Jun 2, 2026Officer or director changeForm8-K
- May 29, 2026Preliminary proxy statementFormPRE 14A
- May 21, 2026FilingFormEFFECT
- May 19, 2026Correspondence with the SECFormCORRESP
- May 18, 2026Letter from the SECFormUPLOAD
- May 12, 2026Shares registered for employeesFormS-8
- May 12, 2026Shelf registration for future offeringsFormS-3
| Filed | Form | What it is | Filing |
|---|---|---|---|
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 16, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Nov 10, 2026 | 10-Q | Quarterly reportfor the period to Sep 30, 2026 | Document |
| Nov 10, 2026 | 8-K | Results of operations | Document |
| Oct 1, 2026 | 8-K | Officer or director change | Document |
| Aug 17, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 14, 2026 | 8-K | Other material events | Document |
| Aug 13, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Aug 11, 2026 | 10-Q | Quarterly reportfor the period to Jun 30, 2026 | Document |
| Aug 11, 2026 | 8-K | Results of operations | Document |
| Jul 28, 2026 | SCHEDULE 13G/A | Over-5% holder statement (passive) (amendment) | Document |
| Jul 27, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 8, 2026 | SCHEDULE 13G | Over-5% holder statement (passive) | Document |
| Jul 6, 2026 | 8-K | Amended articles or bylaws, shareholder vote | Document |
| Jun 8, 2026 | ARS | Annual report to shareholdersfor the period to Dec 31, 2025 | Document |
| Jun 8, 2026 | DEF 14A | Annual meeting proxy statement | Document |
| Jun 2, 2026 | 8-K | Officer or director change | Document |
| May 29, 2026 | PRE 14A | Preliminary proxy statement | Document |
| May 21, 2026 | EFFECT | Filing | Document |
| May 19, 2026 | CORRESP | Correspondence with the SEC | Document |
| May 18, 2026 | UPLOAD | Letter from the SEC | Document |
| May 12, 2026 | S-8 | Shares registered for employees | Document |
| May 12, 2026 | S-3 | Shelf registration for future offerings | Document |
From the company's record at the SEC (EDGAR). The topics of each 8-K are the item codes the company itself filed. Its whole record at the SEC since May 24, 1996: every report, 8-K, meeting and letter. Of its other filings (896 in all), the newest.
The full analysis
What do Achieve Life Sciences's filings show?
The filings are where every one of Achieve Life Sciences's figures comes from. The full Ploutos AI analysis reads everything the company has filed and shows what stands behind it, with a source for every figure.
- A fair value range built from the filings
- Earnings quality, debt and red flags
- Insider and institutional moves
- The case for and the case against
Related pages
The other pages on US stocks, free to read. On the company pages, the last three fiscal years are open to everyone, five with a free account, and every year with Ploutos Investor.
The figures come from the company's SEC filings and the share price, and describe what it has reported. They are not a score or a fair value.